US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Incyte

57.26

+0.46000.81%

Volume:508.53K

Turnover:29.14M

Market Cap:11.08B

PE:381.73

High:58.04

Open:57.48

Low:56.88

Close:56.80

Loading ...

Overview Company News Filings

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

Incyte Had a Bad Week. Investors Are Used to It. -- Barrons.com

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Incyte price target lowered to $72 from $74 at Truist

Incyte Corp. Stock Slips 3.2%, Underperforms Market

INCY Stock Down on Disappointing Skin Disease Study Data

Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating

Incyte Corporation : Deutsche Bank Cuts Target Price to $60 From $70

THOMSON REUTERS

Guggenheim Downgrades Incyte to Neutral From Buy

MT Newswires Live

Incyte downgraded to Market Perform from Outperform at William Blair

Incyte : Wells Fargo Cuts Target Price to $58 From $70

THOMSON REUTERS

Incyte : Guggenheim Cuts to Neutral From Buy

THOMSON REUTERS

Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating

Deutsche Bank Adjusts Price Target on Incyte to $60 From $70, Keeps Hold Rating

MT Newswires Live

Incyte Corporation (INCY): Among the Best Biotech Stocks to Buy According to Billionaires

Post-Bell | US Stocks Rally; Nvidia Drops 2%; Tesla Sinks 5%; Alibaba Gains 5%; Intel Jumps 7%; Arqit Quantum Soars 57%

Tiger Newspress

TD Cowen Reaffirms Their Buy Rating on Incyte (INCY)

Incyte Corp. Stock Slides 8.6%, Underperforms Competitors

Leerink says Incyte’s povo trial results disappoint, drug likely to be approved

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INCY/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"Incyte","latestPrice":57.26,"timestamp":1745341921460,"preClose":56.8,"halted":0,"volume":508526,"delay":0,"floatShares":161370569,"shares":193524350,"eps":0.15,"marketStatus":"Trading","change":0.46,"latestTime":"04-22 13:12:03 EDT","open":57.48,"high":58.04,"low":56.88,"amount":29135907.160898,"amplitude":0.020423,"askPrice":57.28,"askSize":102,"bidPrice":57.23,"bidSize":247,"shortable":3,"etf":0,"ttmEps":0.15,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":56.8,"preHourTrading":{"tag":"盘前","latestPrice":57.05,"preClose":56.8,"latestTime":"09:14 EDT","volume":425,"amount":24150.22975,"timestamp":1745327689812},"postHourTrading":{"tag":"盘后","latestPrice":57,"preClose":56.8,"latestTime":"19:14 EDT","volume":43148,"amount":2450869.15,"timestamp":1745277275199},"volumeRatio":0.531619,"impliedVol":0.3809,"impliedVolPercentile":0.568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":161370569,"roa":"0.86%","roe":"0.76%","lyrEps":0.157476,"volumeRatio":0.531619,"shares":193524350,"dividePrice":0,"high":58.04,"amplitude":0.020423,"preClose":56.8,"low":56.88,"week52Low":50.3498,"pbRate":"3.21","psRate":"2.61","week52High":83.95,"institutionHeld":0.8203,"latestPrice":57.26,"committee":0.415473,"eps":0.15,"divideRate":0,"volume":508526,"delay":0,"ttmEps":0.15,"open":57.48,"prevYearClose":69.07,"prevWeekClose":58.21,"prevMonthClose":60.55,"prevQuarterClose":60.55,"fiveDayClose":59.22,"twentyDayClose":62.78,"sixtyDayClose":72.59,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521403218","title":"The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403218","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403218?lang=en_us&edition=fundamental","pubTime":"2025-03-21 16:46","pubTimestamp":1742546760,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 21, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sarepta Therapeutics SRPT, Incyte INCY, Gilead Sciences, Inc. GILD and VTv Therapeutics Inc. VTVT.It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Sarepta Therapeutics crashed following a report of a patient's death after treatment with Elevidys. Incyte also declined after study data disappointed investors.GILD boasts a market-leading portfolio of HIV treatments both for treating the disease and prevention. The company has two drugs for HIV prevention in its portfolio – Descovy and Truvada. Gilead to looking to get another drug approved for HIV prevention – lenacapavir.Per the report, while programs do provide free pre-exposure prophylaxis, reductions to the s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-sarepta-084600176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","BK4550","LU0109394709.USD","IE00B3T34201.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","VTVT","SRPT","IE0002270589.USD","LU1839511570.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4585","LU2468319806.SGD","QD","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588","IE00BJT1NW94.SGD","LU0234570918.USD","LU0320765992.SGD","IE00BKVL7J92.USD","BK4578","BK4568","ADME","IE00BSNM7G36.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD","INCY","LU2087621335.USD","LU1066051498.USD","LU1571399168.USD","BK4139","BK4503","BK4583","BK4532","GILD","BK4563","IE00B2B36J28.USD","LU0889565916.HKD","IE0002141913.USD","LU1430594728.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2521534426","title":"Incyte Had a Bad Week. Investors Are Used to It. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2521534426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521534426?lang=en_us&edition=fundamental","pubTime":"2025-03-21 14:30","pubTimestamp":1742538600,"startTime":"0","endTime":"0","summary":"Incyte's quest for its next big thing ended in disappointment -- and a stock tumble -- this past week. Unfortunately, the problems go well beyond the recent selloff or the latest trial, as long-term investors in the biotech know all too well.Incyte tumbled more than 8% earlier this week after disappointing Phase 3 study results for povorcitinib, a drug that targets severe hidradenitis suppurativa . Strong Phase 2 data had lifted hopes for the treatment for the condition that causes chronic boils and abscesses under the skin, but the final results were less promising than the prior study in terms of efficacy and perceived competitive positioning.Over the past decade, when the S&P 500 index has risen 175%, Incyte has fallen by a third. The SPDR S&P Biotech and iShares Biotechnology exchange-traded funds have hardly kept pace with the broader market either, but at least both are in positive territory, up around 15% over the period","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU0889565916.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU0289739699.SGD","BK4139","BK4568","LU1066051498.USD","IE00B19Z3581.USD","LU2468319806.SGD","BK4211","BK4578","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00B3T34201.USD","INCY","IE0002270589.USD","LU0320765992.SGD","BK4588","LU0058720904.USD","BK4583","LU0234570918.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2087621335.USD","BK4532","BK4550","LU1585245621.USD","LU1839511570.USD","BK4566","LU1066053197.SGD","IE00BSNM7G36.USD","BK4585","ISBC","GILD"],"gpt_icon":0},{"id":"2521493395","title":"Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2521493395","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521493395?lang=en_us&edition=fundamental","pubTime":"2025-03-21 00:45","pubTimestamp":1742489100,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Sarepta Therapeutics SRPT crashed following report of a patient death after treatment with Elevidys. Incyte INCY also declined after study data disappointed investors.Shares of Sarepta Therapeutics plunged earlier in the week after it reported the death of a patient after treatment with Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy .Per the company, this patient died of acute liver failure. While acute liver injury is a known risk of Elevidys, this is the first time a death has been reported of anyone taking the therapy. However, Sarepta stated that the patient also had a recent cytomegalovirus  infection, which may have contributed to the outcome, as CMV can damage the liver.HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-patient-death-164500168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","VTVT","BK4583","SRPT","LU2089984988.USD","ADME","IE00BSNM7G36.USD","LU1585245621.USD","LU1839511570.USD","BK4166","IE00B2B36J28.USD","IE00B19Z3581.USD","BK4566","LU1066051498.USD","LU2087621335.USD","IE0002141913.USD","QD","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BKVL7J92.USD","BK4139","BK4578","LU0234570918.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU0058720904.USD","IE0002270589.USD","BK4588","BK4503","GILD","LU2468319806.SGD","BK4568","IE00BZ1G4Q59.USD","BK4550","IE00B3T34201.USD","BK4532","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1066053197.SGD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU0889565916.HKD","IE0009355771.USD","BK4563","LU1571399168.USD","INCY","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2520451548","title":"Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2520451548","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520451548?lang=en_us&edition=fundamental","pubTime":"2025-03-20 17:09","pubTimestamp":1742461785,"startTime":"0","endTime":"0","summary":"Wrapping up Q4 earnings, we look at the numbers and key takeaways for the immuno-oncology stocks, including Natera  and its peers.Over the next few years, immuno-oncology companies, which harness the immune system to fight illnesses such as cancer, faces strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 4 immuno-oncology stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 3.5%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 6.9% since the latest earnings results.Founded in 2003 as Gene Security Network before rebranding in 2012, Natera  develops and commercializes genetic tests for prenatal screening, cancer detection, and organ transplant monitoring","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/natera-nasdaq-ntra-q4-earnings-090945808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","NDAQ","INCY","NTRA","REGN","EXAS"],"gpt_icon":0},{"id":"2520181341","title":"Incyte price target lowered to $72 from $74 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2520181341","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520181341?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:06","pubTimestamp":1742385970,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Incyte  to $72 from $74 and keeps a Hold rating on the shares. Following the povorcitinib/povo Phase3 results in moderate to severe hidradenitis suppurativa, HS, the firm believes that the data were statistically significant but missed expectations on magnitude of benefit, adding that it sees povo as “modestly competitive”, the analyst tells investors in a research note. The firm adds that its updated model reflects povo as a second-line opportunity in HS with peak sales of $550M vs. $900M consensus.Discover stocks' market position with detailed  competitor analyses.Read More on INCY:Questions or Comments about the article?Incyte’s Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges. Guggenheim downgrades Incyte on povorcitinib’s ‘somewhat underwhelming’ profile. Incyte downgraded to Market Perform from Outperform at William Blair. Incyte downgraded to Neutral from Buy at Guggenheim. Incyte’s Promising Phase 3 Results an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/incyte-price-target-lowered-72-120610950.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-price-target-lowered-72-120610950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INCY"],"gpt_icon":0},{"id":"2520932171","title":"Incyte Corp. Stock Slips 3.2%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2520932171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520932171?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:35","pubTimestamp":1742330100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Incyte Corp. shed 3.2% to $60.00 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.1% to 5,614.66 and Dow Jones Industrial Average falling 0.6% to 41,581.31.This was the stock's second consecutive day of losses.Incyte Corp. closed 28.5% short of its 52-week high of $83.95, which the company reached on November 8th.The stock demonstrated a mixed performance when compared to some of its competitors, as Alnylam Pharmaceuticals Inc. fell 3.5% to $244.30, Bio-Techne Corp. rose 0.4% to $62.83, and BioMarin Pharmaceutical Inc. remained unchanged.Trading volume totaled 3.3 million, compared to the 50-day average of 1.7 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2520089932","title":"INCY Stock Down on Disappointing Skin Disease Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2520089932","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520089932?lang=en_us&edition=fundamental","pubTime":"2025-03-19 03:00","pubTimestamp":1742324400,"startTime":"0","endTime":"0","summary":"Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis suppurativa .HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.While both the late studies STOP-HS1 and STOP-HS2 studies met their primary endpoint, the results lagged investor expectations, and consequently, shares declined.Povorcitinib is an oral small-molecule JAK1 selective inhibitor currently in phase III studies for HS, vitiligo and prurigo nodularis , as well as phase II trials for asthma and chronic spontaneous urticaria .The phase III studies STOP-HS1  and STOP-HS2  are evaluating the efficacy and safety of povorcitinib in adult patients with moderate to severe HS. Both studies include a 12-week double-blind, placebo-controlled treatment period, followed by a 42-week extension period and 30-day safety follow-up.Data from the STOP-HS2 study s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-stock-down-disappointing-skin-190000520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","LU0289739699.SGD","BK4532","BK4583","BK4007","GSK.UK","BK4166","LU1571399168.USD","AN","LU1169589451.USD","BK4139","INCY","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","BK4214","LU1066053197.SGD","LU2087621335.USD","LU1169590202.USD","LU2089984988.USD","LU1430594728.SGD","GSK","BK4585","BK4588","BK4563","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","BK4503","LU1829250122.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","LU0058720904.USD","BK4568","LU2468319806.SGD","QD","IE0002270589.USD","PN","LU1066051498.USD","BK4566","BK4550","BMRN","LU0889565916.HKD","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2520846639","title":"Incyte’s Povorcitinib Shows Promise but Faces Competitive and Market Challenges, Leading to Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520846639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520846639?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:35","pubTimestamp":1742319311,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Reni Benjamin has reiterated their neutral stance on INCY stock, giving a Hold rating today. Reni Benjamin has given his Hol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incytes-povorcitinib-shows-promise-but-faces-competitive-and-market-challenges-leading-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incytes-povorcitinib-shows-promise-but-faces-competitive-and-market-challenges-leading-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"gpt_icon":0},{"id":"2520262819","title":"Incyte Corporation  : Deutsche Bank Cuts Target Price to $60 From $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2520262819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520262819?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:58","pubTimestamp":1742295486,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nAQN2K65P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","INCY","BK4588","BK4532","BK4139","BK4585"],"gpt_icon":0},{"id":"2520664081","title":"Guggenheim Downgrades Incyte to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520664081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520664081?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:40","pubTimestamp":1742294438,"startTime":"0","endTime":"0","summary":"Incyte (INCY) has an average rating of overweight and mean price target of $75.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INCY"],"gpt_icon":0},{"id":"2520428640","title":"Incyte downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2520428640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520428640?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:36","pubTimestamp":1742294166,"startTime":"0","endTime":"0","summary":"William Blair downgraded Incyte (INCY) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, market-mov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"gpt_icon":0},{"id":"2520476646","title":"Incyte : Wells Fargo Cuts Target Price to $58 From $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2520476646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520476646?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:31","pubTimestamp":1742293908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q10ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4585","BK4550","BK4588","BK4139","INCY"],"gpt_icon":0},{"id":"2520642238","title":"Incyte : Guggenheim Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520642238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520642238?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:27","pubTimestamp":1742293639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q10SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4588","INCY","BK4550","BK4585","BK4532"],"gpt_icon":0},{"id":"2520466649","title":"Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520466649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520466649?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:55","pubTimestamp":1742291729,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Incyte (INCY – Research Report), with a pri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incytes-promising-phase-3-results-and-market-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incytes-promising-phase-3-results-and-market-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"gpt_icon":0},{"id":"2520459476","title":"Deutsche Bank Adjusts Price Target on Incyte to $60 From $70, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520459476","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520459476?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:48","pubTimestamp":1742291337,"startTime":"0","endTime":"0","summary":"Incyte (INCY) has an average rating of overweight and mean price target of $75.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INCY","DB"],"gpt_icon":0},{"id":"2520623982","title":"Incyte Corporation (INCY): Among the Best Biotech Stocks to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623982","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623982?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:32","pubTimestamp":1742290377,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Incyte Corporation  stands against other best biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these tailwinds. Over t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-corporation-incy-among-best-093257980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2471134952.CNY","BK4552","LU1791807156.HKD","BK4550","LU1868836591.USD","USAW.SI","US5Y.BOND","LU2750360997.AUD","LU1868836914.USD","US3Y.BOND","TQQQ","LU2237443549.SGD","MNQmain","LU2471134796.USD","US10Y.BOND","IE0034235188.USD","LU2237438978.USD","BK4532","NQmain","BK4585","IE00B19Z3B42.SGD","BK4077","USJW.SI","IE00BFXG1179.USD","IE00B19Z3581.USD","QID","INCY",".IXIC","LU0061475181.USD","LU1868836757.USD","LU2471134879.HKD","BK4533","LU0106831901.USD","QLD","BK4588","TSYW.SI","PSQ","IE00BSNM7G36.USD","IE0004091025.USD","NVIW.SI","US30Y.BOND","BK4139","US7Y.BOND","US2Y.BOND","FOMC","US6M.BOND","SQQQ","LU2237443895.HKD","US12M.BOND"],"gpt_icon":1},{"id":"1165948196","title":"Post-Bell | US Stocks Rally; Nvidia Drops 2%; Tesla Sinks 5%; Alibaba Gains 5%; Intel Jumps 7%; Arqit Quantum Soars 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165948196","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165948196?lang=en_us&edition=fundamental","pubTime":"2025-03-18 07:40","pubTimestamp":1742254800,"startTime":"0","endTime":"0","summary":"U.S. stocks gained for a second straight session on Monday as investors sought bargains after the Nasdaq and S&P 500's four-week tumble and assessed the latest economic data to gauge the impact of the","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","ARQQ","BABA","QBTS","BIDU","LAES","MU","YINN","JD","TSLA","PDD","NFLX","NVDA","NIO","NCLH","QMCO","INTC",".SPX","AFRM",".DJI","QUBT",".IXIC","SAIC","XPEV"],"gpt_icon":1},{"id":"2520845976","title":"TD Cowen Reaffirms Their Buy Rating on Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520845976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520845976?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:35","pubTimestamp":1742247305,"startTime":"0","endTime":"0","summary":"In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Incyte (INCY – Research Report), with a price target of $88.00. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-incyte-incy-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-incyte-incy-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","TD","INCY"],"gpt_icon":0},{"id":"2520859336","title":"Incyte Corp. Stock Slides 8.6%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520859336","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520859336?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:33","pubTimestamp":1742243580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Incyte Corp. shed 8.6% to $62.01 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.6% to 5,675.12 and the Dow Jones Industrial Average rising 0.9% to 41,841.63.Incyte Corp. closed 26.1% below its 52-week high of $83.95, which the company reached on November 8th.The stock underperformed when compared to some of its competitors, as Alnylam Pharmaceuticals Inc. rose 4.7% to $253.11, Bio-Techne Corp. rose 0.7% to $62.58, and BioMarin Pharmaceutical Inc. rose 3.04% to $71.55.Trading volume totaled 5.2 million, compared to the 50-day average of 1.6 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2520913509","title":"Leerink says Incyte’s povo trial results disappoint, drug likely to be approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2520913509","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520913509?lang=en_us&edition=fundamental","pubTime":"2025-03-18 02:05","pubTimestamp":1742234729,"startTime":"0","endTime":"0","summary":"Leerink analyst Andrew Berens notes that Outperform-rated Incyte (INCY) has reported the results of the two parallel Phase 3 trials evaluating povo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-says-incytes-povo-trial-results-disappoint-drug-likely-to-be-approved?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-says-incytes-povo-trial-results-disappoint-drug-likely-to-be-approved?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","INCY","BK4588","BK4550","BK4532"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"INCY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.75,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"market":"US","date":"2025-02-10","symbol":"INCY","fiscalQuarterEnding":"2024/12","expectedEps":1.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2024-10-29","symbol":"INCY","fiscalQuarterEnding":"2024/09","expectedEps":0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"pre","actualEps":0.73},{"market":"US","date":"2024-07-30","symbol":"INCY","fiscalQuarterEnding":"2024/06","expectedEps":0.59,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722312000000,"reportTimeType":"pre","actualEps":-2.03},{"market":"US","date":"2024-04-30","symbol":"INCY","fiscalQuarterEnding":"2024/03","expectedEps":0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714449600000,"reportTimeType":"pre","actualEps":0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2593,"buy":0.1111,"hold":0.5926,"sell":0.037,"strongSell":0,"meanLabel":"BUY","meanPercent":0.1111,"analysts":27,"updateTime":1742529600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2025-04-21","current":345.394831,"percent":0.909683,"low":-113.710704,"twenty":-53.209696,"median":27.168166,"eighty":48.297524,"high":494.525514,"avg":50.769001,"sd":128.041129,"marketCap":11265052413},"quantilePoints":[{"date":"2020-04-24","current":50.234694,"twenty":-242.897272,"median":-89.637376,"eighty":138.728728,"marketCap":22450186026},{"date":"2020-05-01","current":47.234593,"twenty":-240.25629,"median":-89.009833,"eighty":138.728728,"marketCap":21109423080},{"date":"2020-05-08","current":-55.446277,"twenty":-240.25629,"median":-88.813329,"eighty":138.728728,"marketCap":20850461707},{"date":"2020-05-15","current":-55.561887,"twenty":-240.25629,"median":-87.61529,"eighty":138.728728,"marketCap":20893936398},{"date":"2020-05-22","current":-57.44054,"twenty":-240.25629,"median":-86.968729,"eighty":138.728728,"marketCap":21600400123},{"date":"2020-05-29","current":-58.908779,"twenty":-240.25629,"median":-86.645449,"eighty":138.728728,"marketCap":22152528697},{"date":"2020-06-05","current":-54.053184,"twenty":-240.25629,"median":-86.017905,"eighty":138.728728,"marketCap":20326591683},{"date":"2020-06-12","current":-53.220796,"twenty":-240.25629,"median":-84.952982,"eighty":138.728728,"marketCap":20013573909},{"date":"2020-06-19","current":-60.926164,"twenty":-240.25629,"median":-84.439537,"eighty":138.728728,"marketCap":22911162051},{"date":"2020-06-26","current":-58.631317,"twenty":-240.25629,"median":-82.867507,"eighty":138.728728,"marketCap":22048189439},{"date":"2020-07-02","current":-61.544674,"twenty":-240.25629,"median":-79.400168,"eighty":138.728728,"marketCap":23143751647},{"date":"2020-07-10","current":-60.556214,"twenty":-240.25629,"median":-63.902963,"eighty":138.728728,"marketCap":22772043041},{"date":"2020-07-17","current":-60.180483,"twenty":-240.25629,"median":-62.527569,"eighty":138.728728,"marketCap":22630750295},{"date":"2020-07-24","current":-57.469442,"twenty":-240.25629,"median":-62.1455,"eighty":138.728728,"marketCap":21611268796},{"date":"2020-07-31","current":-57.087931,"twenty":-240.25629,"median":-61.517273,"eighty":138.728728,"marketCap":21467802317},{"date":"2020-08-07","current":-110.947423,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":21198502309},{"date":"2020-08-14","current":-108.589519,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":20747982193},{"date":"2020-08-21","current":-107.719612,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":20581770889},{"date":"2020-08-28","current":-107.479243,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":20535844081},{"date":"2020-09-04","current":-103.57611,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19790080201},{"date":"2020-09-11","current":-100.726022,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19245519480},{"date":"2020-09-18","current":-99.341039,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":18980893587},{"date":"2020-09-25","current":-99.066331,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":18928405806},{"date":"2020-10-02","current":-101.584482,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19409543793},{"date":"2020-10-09","current":-109.585333,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":20938250397},{"date":"2020-10-16","current":-103.736356,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19820698073},{"date":"2020-10-23","current":-102.660419,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19615120933},{"date":"2020-10-30","current":-99.169347,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":18948088724},{"date":"2020-11-06","current":-54.431207,"twenty":-238.00085,"median":-60.917493,"eighty":138.728728,"marketCap":18209524883},{"date":"2020-11-13","current":-54.025346,"twenty":-236.748996,"median":-60.220946,"eighty":138.728728,"marketCap":18073747307},{"date":"2020-11-20","current":-53.632577,"twenty":-235.737346,"median":-59.448784,"eighty":138.728728,"marketCap":17942349653},{"date":"2020-11-27","current":-54.496669,"twenty":-235.092429,"median":-59.088741,"eighty":138.728728,"marketCap":18231424492},{"date":"2020-12-04","current":-54.424661,"twenty":-231.552095,"median":-58.79606,"eighty":138.728728,"marketCap":18207334922},{"date":"2020-12-11","current":-53.22017,"twenty":-230.49601,"median":-58.466762,"eighty":138.728728,"marketCap":17804382117},{"date":"2020-12-18","current":-57.828657,"twenty":-227.269242,"median":-58.139583,"eighty":138.728728,"marketCap":19346114590},{"date":"2020-12-24","current":-57.193681,"twenty":-226.375608,"median":-57.840998,"eighty":138.728728,"marketCap":19133688383},{"date":"2020-12-31","current":-56.938381,"twenty":-225.257464,"median":-57.629891,"eighty":138.728728,"marketCap":19048279908},{"date":"2021-01-08","current":-61.422491,"twenty":-224.421058,"median":-57.561475,"eighty":138.728728,"marketCap":20548403124},{"date":"2021-01-15","current":-59.281902,"twenty":-222.691017,"median":-57.561475,"eighty":138.728728,"marketCap":19832285910},{"date":"2021-01-22","current":-64.080227,"twenty":-221.542059,"median":-57.561475,"eighty":138.728728,"marketCap":21437527250},{"date":"2021-01-29","current":-58.751664,"twenty":-217.425457,"median":-57.561475,"eighty":138.728728,"marketCap":19654899077},{"date":"2021-02-05","current":-59.072425,"twenty":-192.069736,"median":-57.561475,"eighty":138.728728,"marketCap":19762207161},{"date":"2021-02-12","current":-62.693578,"twenty":-158.640962,"median":-57.561475,"eighty":138.728728,"marketCap":18538302884},{"date":"2021-02-19","current":-59.879523,"twenty":-157.272898,"median":-57.561475,"eighty":138.728728,"marketCap":17706195248},{"date":"2021-02-26","current":-58.481789,"twenty":-155.620306,"median":-57.561475,"eighty":138.728728,"marketCap":17292889474},{"date":"2021-03-05","current":-59.67135,"twenty":-153.451761,"median":-57.511438,"eighty":138.728728,"marketCap":17644639069},{"date":"2021-03-12","current":-58.742005,"twenty":-151.55119,"median":-57.511438,"eighty":138.728728,"marketCap":17369834697},{"date":"2021-03-19","current":-59.009656,"twenty":-147.610696,"median":-57.511438,"eighty":138.728728,"marketCap":17448978356},{"date":"2021-03-26","current":-60.779128,"twenty":-145.501961,"median":-57.535851,"eighty":138.728728,"marketCap":17972205879},{"date":"2021-04-01","current":-61.715907,"twenty":-144.624845,"median":-57.535851,"eighty":138.728728,"marketCap":18249208685},{"date":"2021-04-09","current":-59.448307,"twenty":-143.480065,"median":-57.511438,"eighty":138.728728,"marketCap":17578686020},{"date":"2021-04-16","current":-61.470561,"twenty":-142.437133,"median":-57.511438,"eighty":138.728728,"marketCap":18176660331},{"date":"2021-04-23","current":-63.636305,"twenty":-140.864214,"median":-57.511438,"eighty":138.728728,"marketCap":18817064417},{"date":"2021-04-30","current":-63.487587,"twenty":-139.050719,"median":-57.511438,"eighty":138.728728,"marketCap":18773089038},{"date":"2021-05-07","current":38.029737,"twenty":-138.140751,"median":-57.417418,"eighty":138.728728,"marketCap":18196468486},{"date":"2021-05-14","current":37.974581,"twenty":-137.538187,"median":-57.041687,"eighty":138.728728,"marketCap":18170077669},{"date":"2021-05-21","current":38.038929,"twenty":-136.154034,"median":-56.859827,"eighty":138.728728,"marketCap":18200866956},{"date":"2021-05-28","current":38.507751,"twenty":-134.962092,"median":-56.671737,"eighty":138.728728,"marketCap":18425188903},{"date":"2021-06-04","current":38.300918,"twenty":-134.368461,"median":-56.473605,"eighty":138.728728,"marketCap":18326223338},{"date":"2021-06-11","current":37.956196,"twenty":-133.781698,"median":-56.211759,"eighty":138.728728,"marketCap":18161280730},{"date":"2021-06-18","current":38.590485,"twenty":-133.212304,"median":-55.917182,"eighty":138.728728,"marketCap":18464775128},{"date":"2021-06-25","current":39.909621,"twenty":-131.986896,"median":-55.561887,"eighty":138.728728,"marketCap":19095955507},{"date":"2021-07-02","current":38.415826,"twenty":-131.334231,"median":-55.337977,"eighty":138.728728,"marketCap":18381204207},{"date":"2021-07-09","current":37.707996,"twenty":-130.920252,"median":-54.86823,"eighty":138.728728,"marketCap":18042522053},{"date":"2021-07-16","current":36.002771,"twenty":-129.331126,"median":-54.431207,"eighty":138.728728,"marketCap":17226605953},{"date":"2021-07-23","current":36.448612,"twenty":-128.489296,"median":-54.267553,"eighty":138.728728,"marketCap":17439931726},{"date":"2021-07-30","current":35.552334,"twenty":-127.966687,"median":-54.053184,"eighty":138.728728,"marketCap":17011080945},{"date":"2021-08-06","current":49.904723,"twenty":-127.053631,"median":-53.781502,"eighty":138.728728,"marketCap":16849731024},{"date":"2021-08-13","current":48.053736,"twenty":-126.920152,"median":-53.75838,"eighty":137.245403,"marketCap":16224767213},{"date":"2021-08-20","current":48.98904,"twenty":-126.920152,"median":-53.75838,"eighty":135.125566,"marketCap":16540561648},{"date":"2021-08-27","current":49.499207,"twenty":-126.920152,"median":-53.75838,"eighty":133.981527,"marketCap":16712813157},{"date":"2021-09-03","current":49.767371,"twenty":-126.920152,"median":-53.75838,"eighty":132.851508,"marketCap":16803355618},{"date":"2021-09-10","current":46.516696,"twenty":-126.920152,"median":-53.75838,"eighty":131.356968,"marketCap":15705804331},{"date":"2021-09-17","current":49.701965,"twenty":-126.920152,"median":-53.75838,"eighty":73.50992,"marketCap":16781272091},{"date":"2021-09-24","current":45.130091,"twenty":-126.920152,"median":-53.75838,"eighty":72.160274,"marketCap":15237633561},{"date":"2021-10-01","current":44.613384,"twenty":-126.920152,"median":-53.75838,"eighty":71.599051,"marketCap":15063173698},{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-21","current":345.394831,"twenty":-53.209696,"median":27.168166,"eighty":48.297524,"marketCap":11265052413}],"updateTime":1745320785623}}}